• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Exemasin-Vit 25 mg
    / Vitamed

    Active Ingredient
    Exemestane 25 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Coated Tablets

    30 X 25 mg

    partial basket chart

    Related information


    One 25 mg tablet should be taken by mouth once a day at approximately the same time.
    Please refer to the license holder for further details.


    Treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.
    Treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies.
    Indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.


    Hypersensitivity to active substance or to any of its excipients. Pregnancy. Breast-feeding. Women of child bearing potential.

    Genepharm SA